CCK-BR Antibodies

Santa Cruz Biotechnology provides a broad selection of CCK-BR monoclonal antibodies for research focused on understanding the cholecystokinin B receptor (CCK-BR). CCK-BR Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The cholecystokinin B receptor plays a crucial role in mediating the effects of cholecystokinin, a hormone involved in digestion and appetite regulation. CCK-BR is also implicated in various physiological processes, including anxiety and pain modulation, making it a significant target for therapeutic research. Understanding the function and signaling pathways of CCK-BR can provide insights into gastrointestinal disorders and potential treatment strategies. Research has shown that CCK-BR expression patterns vary across different tissues and cell types, offering opportunities to explore its diverse biological functions. CCK-BR signaling mechanisms continue to be an active area of investigation in neuroscience and gastroenterology. Santa Cruz Biotechnology monoclonal antibodies for CCK-BR enable researchers to advance scientific understanding of this important receptor and its role in human health and disease.